This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quyyumi, A. A. Search for Related Content PubMed PubMed Citation Articles by Quyyumi, A. A. Related Collections Pathophysiology Mechanism of atherosclerosis/growth factors

(Circulation. 2006;114:1137-1139.)
© 2006 American Heart Association, Inc.

Editorial

Inflamed Joints and Stiff Arteries

Is Rheumatoid Arthritis a Cardiovascular Risk Factor?

Arshed A. Quyyumi, MD

From the Division of Cardiology, Emory University, Atlanta, Ga.

Correspondence to Arshed A. Quyyumi, MD, Professor of Medicine, Division of Cardiology, 1364 Clifton Rd, Ste. D403C, Atlanta, GA 30322. E-mail aquyyum@emory.edu

Key Words: Editorials • arteries • atherosclerosis • endothelium • immune system • risk factors • stroke

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular events, with an estimated 70% excess mortality rate that can be ascribed to cardiovascular causes in up to 50% of cases.^1,2 A 3-fold-increased adjusted risk of myocardial infarction has been reported, particularly in subjects with longer disease duration.³ This has prompted recommendations that RA be considered an independent risk factor for atherosclerosis.² Mechanisms underlying this increased susceptibility remain uncertain and range from exposure to traditional cardiovascular risk factors to enhanced inflammation and oxidative stress emanating from the synovium leading to early vascular disease,⁴ and extend to adverse cardiovascular effects of medications.

Article p 1185

Epidemiological studies have found either no increase or often a decreased prevalence of traditional cardiovascular risk factors in patients with RA.^2,5 However, the dyslipidemia observed in RA is associated with low total and HDL cholesterol and high triglyceride levels, a pattern that is associated with a more dense, easily oxidizable, and intensely atherogenic low-density lipoprotein particle.⁵ Hyperinsulinemia and insulin resistance can occur in RA, an abnormality that correlates with underlying inflammation.⁶ The potential mechanisms for this include the use of glucocorticoids and the direct effects of cytokines such as tumor necrosis factor (TNF)- on impeding insulin-mediated glucose uptake in skeletal muscle and on lipolysis.⁵ It appears that an atherogenic modification of existing cardiovascular risk factors by the RA milieu, presumably as a result of increased systemic inflammation and oxidative stress, accounts for some of the increased cardiovascular risk. This viewpoint is substantiated by the observed . . . [Full Text of this Article]

This article has been cited by other articles:

				M. A. Crilly, V. Kumar, H. J. Clark, N. W. Scott, A. G. MacDonald, and D. J. Williams Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors Rheumatology, December 1, 2009; 48(12): 1606 - 1612. [Abstract] [Full Text] [PDF]

				B. J Crowe, H. A. Xia, J. A Berlin, D. J Watson, H. Shi, S. L Lin, J. Kuebler, R. C Schriver, N. C Santanello, G. Rochester, et al. Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team Clinical Trials, October 1, 2009; 6(5): 430 - 440. [Abstract] [PDF]

				K. S. Stamatelopoulos, G. D. Kitas, C. M. Papamichael, E. Chryssohoou, K. Kyrkou, G. Georgiopoulos, A. Protogerou, V. F. Panoulas, A. Sandoo, N. Tentolouris, et al. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1702 - 1708. [Abstract] [Full Text] [PDF]